Primary Progressive Multiple Sclerosis
Primary Progressive Multiple Sclerosis (PPMS) is a type of multiple sclerosis that leads to a steady decline in function from the beginning, without the typical flare-ups seen in other forms of MS.
We are exploring the use of stem cells from fat tissue to treat primary progressive multiple sclerosis. This study aims to assess the safety and potential benefits of this new approach.
Health conditions and diseases that the clinical trial is designed to study and treat.
Primary Progressive Multiple Sclerosis (PPMS) is a type of multiple sclerosis that leads to a steady decline in function from the beginning, without the typical flare-ups seen in other forms of MS.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.